Identification of Factors Influencing Cumulative Long-Term Radiation Exposure in Patients Undergoing EVAR

Table 2

Effective doses from CTA and interventional procedures [in mSv].

Effective doses from CTA and endovascular procedures [in mSv]
	Min. ED; (mSv)	1st; quartile; (mSv)	Median ED; (mSv)	3rd; quartile; (mSv)	Max.; ED; (mSv)	p
CTA	3.0	19.7	24.5	30.3	60.3
Native phase	0.9	2.9	4.5	5.6	18.8
Arterial phase	1.9	9.6	12.7	15.7	27.3
Late venous phase	2.6	7.7	09.6	12.4	23.4
Mono- or biphasic CTA versus			17.6
Triphasic CTA			26.6			<0.001
CTA pelvis/abdomen versus			23.8
CTA pelvis/abdomen/thorax			26.4			0.012
EVAR	3.6	14.3	23.2	40.8	109.2
EVAR in normal weight patient versus			13.4
EVAR in overweight patient versus			18.5
EVAR in obese patient			45.7			<0.001
Secondary endovascular procedures	2.6	13.6	20.8	25.5	60.7